STOCK TITAN

American Well Corp - AMWL STOCK NEWS

Welcome to our dedicated page for American Well news (Ticker: AMWL), a resource for investors and traders seeking the latest updates and insights on American Well stock.

American Well Corp (AMWL) is a leading telehealth platform enabling digital care solutions across healthcare ecosystems. This page serves as the definitive source for verified news and official announcements from the company, providing stakeholders with timely insights into strategic developments.

Access comprehensive updates including earnings reports, technology innovations, partnership announcements, and regulatory milestones. Investors and industry observers can track AMWL's progress in advancing hybrid care models and expanding its digital health infrastructure.

All content is curated to ensure relevance to AMWL's operations in virtual care delivery, platform enhancements, and collaborations with healthcare providers. Bookmark this page for efficient monitoring of the company's evolving role in shaping accessible, technology-driven healthcare solutions.

Rhea-AI Summary

Amwell (NYSE: AMWL), a leader in telehealth, will report its fourth quarter and full year operating results for 2020 on March 24, 2021. A live conference call and webcast will follow at 5:00 p.m. ET to discuss these results and provide a business update. Interested parties can access the webcast via the investors.amwell.com website or call (833) 979-2840 for the live call. The company supports over 2,000 hospitals and 55 health plans, covering 80 million lives with telehealth solutions.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-8.86%
Tags
conferences
-
Rhea-AI Summary

Amwell (NYSE: AMWL) has announced the launch of the Hospital TV 100, a new Carepoint device aimed at enhancing telehealth connectivity in hospitals. This device allows hospitals to use existing televisions as telehealth endpoints, enabling care teams to monitor patients remotely without additional infrastructure costs. With over 1,200 installations across 50 locations at Intermountain Healthcare, this innovation addresses strained resources amid the COVID-19 pandemic. Amwell continues to expand its telehealth services, underscoring its commitment to improving healthcare accessibility.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.12%
Tags
none
-
Rhea-AI Summary

Amwell (NYSE: AMWL) announced a public offering of 11,280,647 shares of its Class A common stock at a price of $27.50 per share, led by certain stockholders. The offering includes a 30-day option for underwriters to purchase an additional 1,692,097 shares. Notably, Amwell will not receive any proceeds from this offering. The transaction is expected to close on January 20, 2021, subject to customary conditions. The offering is led by Morgan Stanley, Goldman Sachs, Piper Sandler, and UBS Investment Bank, with the registration statement effective since January 14, 2021.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.13%
Tags
Rhea-AI Summary

Amwell (NYSE: AMWL) announced the commencement of its public offering roadshow, involving the sale of 11,280,647 shares of Class A common stock by certain Selling Stockholders. An additional 1,692,097 shares may be purchased by underwriters. Amwell will not receive proceeds from this offering, which is led by Morgan Stanley and Goldman Sachs. A registration statement has been filed with the SEC, pending effectiveness. This move highlights Amwell's focus on expanding its telehealth services, which already connect over 80 million lives.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.96%
Tags
-
Rhea-AI Summary

Amwell (NYSE: AMWL) has announced the launch of Amwell Psychiatric Care, a new telepsychiatry solution aimed at hospitals and health systems to address the escalating demand for behavioral healthcare in the U.S. This service offers 24/7 access to board-certified psychiatrists and seeks to improve patient throughput in emergency departments. Asana Integrated Medical Group, part of Amwell since 2019, has received The Joint Commission's Gold Seal for Behavioral Healthcare Accreditation, reinforcing Amwell's commitment to quality care in the mental health sector.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.27%
Tags
none
-
Rhea-AI Summary

Amwell (NYSE: AMWL) announced new leadership appointments, with Egbert van Acht as Executive Vice Chairman and Frank McGillin as CEO. This joint venture with Cleveland Clinic aims to enhance digital health services, especially in telemedicine, which has surged during the COVID-19 pandemic. The company focuses on offering high-acuity care via its MyConsult platform, supporting over 2,000 conditions. Both leaders bring extensive experience from global organizations, highlighting the company's strategy to leverage Cleveland Clinic's expertise and Amwell's technology for improved patient care.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.36%
Tags
none
Rhea-AI Summary

Amwell (NYSE: AMWL) announced the participation of Ido Schoenberg and Keith Anderson in the 32nd Annual Piper Sandler Virtual Healthcare Conference from December 1-3, 2020. They will engage in a fireside chat on December 3 at 1:00 p.m. EDT. A live audio webcast, along with a replay, will be accessible on Amwell's investor relations website for approximately 90 days following the presentation.

Amwell is a leading telehealth platform, empowering over 2,000 hospitals and 55 health plan partners. The company connects providers and patients, delivering affordable, high-quality healthcare.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.2%
Tags
conferences
-
Rhea-AI Summary

Amwell, a telehealth leader (NYSE: AMWL), announced its Q3 2020 financial results, showing significant growth amid increased telehealth demand. Total active providers surged to ~62,000, with total visits reaching ~1.41 million, up from 255,000 YOY. Total revenue was $62.6 million, compared to $34.7 million last year, driven by strong subscription and visit revenues. However, gross margin declined to 32.7% from 45.1%, and the net loss expanded to $(64.6) million from $(24.1) million. The company expects full-year revenue between $235 and $239 million.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-18.04%
Tags
none
-
Rhea-AI Summary

Amwell (NYSE: AMWL) has announced new telehealth products including Amwell Now, Touchpoint Tablet software, and the C500 telemedicine cart to enhance virtual care delivery amid the ongoing COVID-19 pandemic. These offerings aim to simplify and integrate telehealth services for healthcare providers and patients, improving accessibility and efficiency. Amwell Now provides quick video visit capabilities, while the Touchpoint software enables bedside video connectivity. The C500 cart features advanced technology for remote exams, supporting diverse healthcare specialties.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.52%
Tags
none
Rhea-AI Summary

Amwell (NYSE: AMWL) has achieved full URAC Accreditation in Telemedicine, reinforcing its commitment to quality virtual care during the ongoing pandemic. This independent accreditation, awarded for the second time, showcases Amwell's adherence to URAC's rigorous standards for safety, privacy, and quality in healthcare delivery. Ido Schoenberg, Co-CEO of Amwell, emphasized that this accreditation ensures their clients and patients can trust in their telehealth services. URAC's President highlighted the significance of this achievement in promoting value-based care access amidst rapid changes in the telehealth industry.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
13%
Tags
none
American Well Corp

NYSE:AMWL

AMWL Rankings

AMWL Stock Data

108.96M
12.27M
8.62%
48.3%
2.77%
Health Information Services
Services-business Services, Nec
Link
United States
Boston